A 70-year-old with diabetes, HTN, and CAD comes for annual visit. He is on lisinopril, metformin, atorvastatin 40, aspirin 81, and metoprolol succinate. His ASCVD 10-year risk is 22%. LDL is 95 mg/dL. Per 2018 ACC/AHA lipid guidelines, what is the best next step?
- AContinue current regimen
- BAdd ezetimibe (and consider PCSK9 inhibitor if LDL remains elevated)
- CStop atorvastatin
- DSwitch to pravastatin